---
name: AAV Technology - Catalent Cell & Gene Therapy
slug: biologics
site: cro
website_domain: biologics.catalent.com
summary: AAV Technology - Catalent Cell & Gene Therapy provides CRO services. Discovery_source:brave.
tagline: Global biologics CDMO partner for cell and gene therapies—from development to commercial supply.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: Catalent
parent_slug: catalent
hq_country: 
tier2_domain_verified: false
updated_at: 2026-06-10T01:45:01.804Z
services_count: 2
modalities_count: 3
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# AAV Technology - Catalent Cell & Gene Therapy

Global biologics CDMO partner for cell and gene therapies—from development to commercial supply.

Listed on cro.directory.

## Summary

AAV Technology - Catalent Cell & Gene Therapy provides CRO services. Discovery_source:brave.

## At a glance

- Parent: [Catalent](/companies/catalent)

## Services

- Translational Research
- Analytical Method Development & Validation

## Modalities

- Gene Therapy
- Cell Therapy
- AAV / Viral Vector Platform

## Long description

Catalent's AAV Technology and Cell & Gene Therapy division is a global biologics CDMO partner offering end-to-end services for cell and gene therapies. The organization provides comprehensive support spanning cell line and viral vector development, drug substance manufacturing, fill/finish operations, and commercial supply. Services are backed by advanced technologies, global manufacturing capacity, and decades of proven expertise in biologics development and commercialization. The team emphasizes collaboration, flexibility, and quality assurance throughout program lifecycle, from early development through clinical and commercial stages.

_Profile last updated: 2026-06-10T01:45:01.804Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.